Market Closed - 15:55:08 2026-08-21 EDT 5-day change 1st Jan Change
0.003000 EUR 0.00% Intraday chart for MagForce AG 0.00% +50.00%
3 months-14.29%
6 months-62.50%
1 month-33.33%
3 months-14.29%
6 months-62.50%
Current year+50.00%
1 week 0
Extreme 0.003
0.01
1 month 0
Extreme 0.003
0.01
Current year 0
Extreme 0.001
0.02
1 year 0
Extreme 0.001
0.02
3 years 0
Extreme 0.0002
0.02
5 years 0
Extreme 0.0002
0.02
10 years 0
Extreme 0.0002
0.02
Manager TitleAgeSince
Chief Executive Officer 86 2013-08-31
Director of Finance/CFO 55 2012-09-30
Director TitleAgeSince
Chairman 54 2021-08-11
Director/Board Member 45 -
Director/Board Member 54 -
Date Insider Type Main position Quantity % Market Cap.
12/16/20 Buy

Chief Executive Officer

250,000 0.9045%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-25.00%+50.00% 107K
+1.09%+5.26%+4.52%+23.38% 51.61B
-1.07%+2.82%+465.96%+570.70% 44.89B
+1.47%+9.79%+35.92%+20.21% 42.77B
+1.44%+7.77%+19.38%+84.65% 42.58B
-0.93%-4.33%+16.18%+55.82% 31.82B
+1.32%+7.30%+33.89%+148.53% 17.33B
-0.60%+1.93% - - 16.63B
+0.03%+3.41%+6.55%+29.84% 14.76B
+1.28%+5.41%+82.40%+46.13% 14.09B
Average +0.40%+3.99%+71.09%+114.36% 27.65B
Weighted average by Cap. +0.49%+4.72%+99.57%+141.38%

Financials

2020 2021
Net sales 1.5M 1.75M 1.41M 1.29M 2.41M 168M 2.45M 16.61M 6.48M 84.29M 6.59M 6.44M 279M 1.08M 1.26M 1.01M 923K 1.73M 120M 1.75M 11.91M 4.64M 60.44M 4.72M 4.62M 200M
Net income 14.75M 17.22M 13.8M 12.63M 23.7M 1.65B 24.02M 163M 63.57M 827M 64.64M 63.24M 2.74B -10.57M -12.34M -9.89M -9.06M -17M -1.18B -17.22M -117M -45.59M -593M -46.35M -45.34M -1.96B
Net Debt - -
Logo MagForce AG
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
Employees
33
Date Price Change Volume
26-08-21 €0.003000 0.00% 37,605
26-08-20 €0.003000 0.00% 0
26-08-19 €0.003000 0.00% 23,020
26-08-18 €0.003000 -14.29% 14,655
26-08-17 €0.003500 +16.67% 6,755